Published online Aug 6, 2024. doi: 10.12998/wjcc.v12.i22.5159
Revised: May 30, 2024
Accepted: June 18, 2024
Published online: August 6, 2024
Processing time: 118 Days and 14.1 Hours
Lower extremity lymphedema is a common complication following treatment for gynecological malignancies. Its incidence rate can reach up to 70%, affecting ~20 million people worldwide. However, specialized treatment centers are scarce, and there is a lack of consensus on treatment approaches. Furthermore, there are even fewer reports on the systematic and effective treatment of severe lymphedema with malformations. Effective management of this condition remains a significant challenge for clinicians.
A 40-year-old woman developed bilateral leg swelling 6 years after receiving treatment for endometrial cancer. Since August 2018, she experienced > 30 episodes of lymphangitis. Upon presentation, she exhibited bilateral leg swelling and deformation, with four large swellings in the posterior thigh that impeded movement, and pain in the limbs. Skin manifestations included lichenoid lesions and features of deep sclerosis. Radionuclide lymphoscintigraphy confirmed the diagnosis of lower limb lymphedema. After 6 mo of complex decongestive the
The combined application of CDT and LVA therapy demonstrates significant positive effects in the treatment of severe, deformed stage III lymphedema.
Core Tip: We report a 40-year-old woman who developed severe lower extremity lymphedema following treatment for endometrial cancer. She underwent a combination of complex decongestive therapy (CDT) and lymphaticovenous anastomosis (LVA). This significantly improved lower limb motor function, with the near-complete resolution of discomfort and a substantial return to normal limb appearance. This case suggests that combined application of CDT and LVA offers a promising therapeutic approach for severe, deformed lymphedema. This minimally invasive strategy, with its associated benefits of minimal surgical trauma and good postoperative aesthetics, has the potential to equip future clinicians with improved management strategies for severely deformed lower extremity lymphedema.
